financetom
Business
financetom
/
Business
/
--lululemon athletica Guides For Q2 EPS of $2.92-$2.97 on Revenue of $2.40-$2.42 Billion, vs CIQ Analyst Consensus of $3.03/Share on Revenue of $2.45 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--lululemon athletica Guides For Q2 EPS of $2.92-$2.97 on Revenue of $2.40-$2.42 Billion, vs CIQ Analyst Consensus of $3.03/Share on Revenue of $2.45 Billion
Jun 5, 2024 1:22 PM

04:06 PM EDT, 06/05/2024 (MT Newswires) --

Price: 337.02, Change: +28.75, Percent Change: +9.33

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
LifeMD, Novo Nordisk Collaborate on Discounted Wegovy Bundle
LifeMD, Novo Nordisk Collaborate on Discounted Wegovy Bundle
May 26, 2025
08:43 AM EDT, 05/22/2025 (MT Newswires) -- LifeMD ( LFMD ) said Thursday it launched a $299 introductory offer for new self-pay patients prescribed Wegovy, as part of a collaboration with Novo Nordisk ( NVO ) . The company said the offer includes a discounted $199 price for the medication and $100 for LifeMD's ( LFMD ) virtual weight loss...
Evaxion Biotech Doses First Patient in Extension of Cancer Vaccine Trial
Evaxion Biotech Doses First Patient in Extension of Cancer Vaccine Trial
May 26, 2025
08:42 AM EDT, 05/22/2025 (MT Newswires) -- Evaxion Biotech (EVAX) said Thursday it has dosed the first patient in the one-year extension of the phase 2 trial of its personalized cancer vaccine EVX-01. The extension further evaluates the potential of the vaccine as a potential treatment for advanced melanoma, or skin cancer, particularly its long-term clinical and immune benefits, the...
Solar stocks plummet after Trump's tax bill advances in US House
Solar stocks plummet after Trump's tax bill advances in US House
May 26, 2025
May 22 (Reuters) - Shares of U.S. solar companies fell sharply in premarket trade on Thursday after the House of Representatives advanced President Donald Trump's sweeping tax and spending bill, which may end numerous green-energy subsidies that have supported the renewable energy sector. Sunrun ( RUN ) led the market rout, with shares falling as much as 33%, Complete Solaria...
Copyright 2023-2026 - www.financetom.com All Rights Reserved